Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 1.59 Million USD | 213.78% |
| 2021 | 508.64 Thousand USD | 110.67% |
| 2020 | 241.44 Thousand USD | 241343.0% |
| 2019 | 100.00 USD | -92.93% |
| 2018 | 1415.00 USD | 0.0% |
| 2014 | 186.21 Thousand USD | 58.91% |
| 2013 | 117.18 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2022 Q4 | 1.59 Million USD | -30.22% |
| 2022 FY | 1.59 Million USD | 213.78% |
| 2022 Q3 | 2.28 Million USD | -2.71% |
| 2022 Q2 | 2.35 Million USD | 384.53% |
| 2022 Q1 | 485.22 Thousand USD | -4.6% |
| 2021 Q3 | 272.51 Thousand USD | 47.12% |
| 2021 Q1 | 196.14 Thousand USD | -18.76% |
| 2021 Q4 | 508.64 Thousand USD | 86.65% |
| 2021 Q2 | 185.23 Thousand USD | -5.56% |
| 2021 FY | 508.64 Thousand USD | 110.67% |
| 2020 Q3 | 65.74 Thousand USD | 22.78% |
| 2020 FY | 241.44 Thousand USD | 241343.0% |
| 2020 Q1 | 19.18 Thousand USD | 19085.0% |
| 2020 Q2 | 53.54 Thousand USD | 179.11% |
| 2020 Q4 | 241.44 Thousand USD | 267.23% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 100.00 USD | 0.0% |
| 2019 FY | 100.00 USD | -92.93% |
| 2018 FY | 1415.00 USD | 0.0% |
| 2015 Q1 | 170.79 Thousand USD | -8.28% |
| 2015 Q2 | 195.9 Thousand USD | 14.7% |
| 2015 Q3 | 57.9 Thousand USD | -70.44% |
| 2014 Q1 | 119.19 Thousand USD | 0.0% |
| 2014 Q2 | 121.22 Thousand USD | 1.71% |
| 2014 Q3 | 123.22 Thousand USD | 1.64% |
| 2014 Q4 | 186.21 Thousand USD | 51.12% |
| 2014 FY | 186.21 Thousand USD | 58.91% |
| 2013 FY | 117.18 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | 100.0% |
| Arrayit Corporation | 7.49 Million USD | 100.0% |
| Atlantic International Corp. | 3.82 Million USD | 100.0% |
| Biocept, Inc. | 22.01 Million USD | 100.0% |
| Bioqual, Inc. | 18.93 Million USD | 100.0% |
| CardioGenics Holdings Inc | 1.79 Million USD | 100.0% |
| DermTech, Inc. | 64.75 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 100.0% |
| iMD Companies, Inc. | 1.67 Million USD | 100.0% |
| IDenta Corp. | 1.01 Million USD | 100.0% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | 100.0% |
| InVitro International | 78.99 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | 100.0% |
| Medical Imaging Corp. | 9.51 Million USD | 100.0% |
| NovelStem International Corp. | 4.2 Million USD | 100.0% |
| Optigenex Inc. | 9.57 Million USD | 100.0% |
| PharmChem, Inc. | 558.64 Thousand USD | 100.0% |
| Proteome Sciences plc | 18.48 Million USD | 100.0% |
| Response Genetics, Inc | 15.86 Million USD | 100.0% |
| Rennova Health, Inc. | 49.66 Million USD | 100.0% |
| RushNet, Inc. | 6.23 Million USD | 100.0% |
| ScreenPro Security Inc. | 1.6 Million USD | 100.0% |
| Stella Diagnostics Inc. | 18 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 100.0% |
| Todos Medical Ltd. | 50.15 Million USD | 100.0% |